IP Library Granted Patent US 8,299,254
Granted Patent B2
US 8,299,254 · App. 12/543,240 · Granted Oct 30, 2012

Preparation of pyridonecarboxylic acid antibacterials

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,299,254
App. No.
12/543,240
Granted
Oct 30, 2012
Kind
B2
Abstract

A process for making 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid, and therapeutically acceptable salts thereof, and intermediates used in the process are disclosed.

Claims (19)

1. A process for making 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or a salt thereof, comprising: (k) reacting ethyl 1-(6-amino-3,5-difluoropyridin-2-yl)-6-fluoro-7-(3-(isobutyryloxy)azetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate or a salt thereof and a chlorinating agent and isolating or not isolating the product; and (1) reacting the product of step (k) and a hydroxide base.

2. The process of claim 1 further comprising isolating the product of step (1).

3. The process according to claim 1 wherein the chlorinating agent is N-chlorosuccinimide, thionyl chloride, Cl 2 , Cl 2 O, or 1,3-dimethyl-5,5-dichlorohydantoin, with or without water, and with or without an acid.

4. The process according to claim 3 wherein the chlorinating agent is N-chlorosuccinimide.

5. The process according to claim 3 wherein the chlorinating agent is thionyl chloride.

6. The process according to claim 3 wherein the chlorinating agent is Cl 2 .

7. The process according to claim 3 wherein the chlorinating agent is Cl 2 O.

8. The process according to claim 3 wherein the chlorinating agent is 1,3-dimethyl-5,5-dichlorohydantoin.

9. The process according to claim 3 with an acid wherein the acid is sulfuric acid, phosphoric acid, trifluoroacetic acid, or perchloric acid.

10. The process according to claim 4 with an acid wherein the acid is sulfuric acid, phosphoric acid, trifluoroacetic acid, or perchloric acid.

11. The process according to claim 5 with an acid wherein the acid is sulfuric acid, phosphoric acid, trifluoroacetic acid, or perchloric acid.

12. The process according to claim 6 with an acid wherein the acid is sulfuric acid, phosphoric acid, trifluoroacetic acid, or perchloric acid.

13. The process according to claim 7 with an acid wherein the acid is sulfuric acid, phosphoric acid, trifluoroacetic acid, or perchloric acid.

14. The process according to claim 8 with an acid wherein the acid is sulfuric acid, phosphoric acid, trifluoroacetic acid, or perchloric acid.

15. The process according to any of claims 1 , 2 , and 3 to 14 wherein the hydroxide base is the hydroxide base of sodium, potassium, lithium, barium, or mixtures thereof.

16. The process according to claim 1 wherein the hydroxide base is sodium hydroxide.

17. The process according to claim 1 wherein the hydroxide base is potassium hydroxide.

18. The process according to claim 1 wherein the hydroxide base is lithium hydroxide.

19. The process according to claim 1 wherein the hydroxide base is barium hydroxide.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jan 5, 2018
From: SUCHARD SA LLC
To: MELINTA SUBSIDIARY CORP. (F/K/A MELINTA THERAPEUTICS, INC.)
Reel/Frame 044547/0939 →
SECURITY INTEREST Recorded Jun 28, 2017
From: MELINTA THERAPEUTICS, INC.
To: SUCHARD SA LLC
Reel/Frame 042854/0753 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2013
From: ABBOTT LABORATORIES
To: ABBVIE INC.
Reel/Frame 030185/0141 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 16, 2010
From: HAIGHT, ANTHONY; BARNES, DAVID M.; ZHANG, GEOFF G.Z.
To: ABBOTT LABORATORIES
Reel/Frame 024543/0291 →